This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Heart Failure Innovation Research 
DAIC
FEBRUARY 10, 2025
Additionally, the algorithm demonstrated its ability to pinpoint specific, clinically relevant segments of heart sound recordings, offering a transparent and explainable AI approach that aligns with physicians diagnostic workflows. The companys goal is to develop pioneering AI solutions that address significant gaps in healthcare delivery.
64 
Medical Xpress - Cardiology
JANUARY 29, 2025
The study is a milestone for the clinical application of the "heart patch" as an innovative treatment option for patients with advanced heart failure at the University Medical Center Gttingen (UMG) and University Medical Center Schleswig-Hostein, Canpus Lbeck (UKSH). The results have been published in Nature.
110 
DAIC
JULY 30, 2024
The Heart Rhythm Society (HRS) is preparing for HRX 2024, the third annual event of its kind, which will be held from September 5-7, 2024, in Atlanta, GA, gathering cardiovascular health innovators together to explore discoveries and advance partnerships between medicine and technology. On Thursday, Sept.
105 
Frontiers in Cardiovascular Medicine
JANUARY 31, 2025
IntroductionVentricular assist devices (VADs) are lifesavers for people with advanced heart failure. This bibliometric work will aid in identifying the newest trends and developments in this field and highlight the areas where more research is needed.
80 
Medical Xpress - Cardiology
JULY 24, 2024
Increasing ketone supply to the heart in mice with heart failure with preserved ejection fraction (HFpEF) allowed their hearts to utilize more ketones and produce more energy, according to preliminary research presented today at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2024.
Becker's Hospital Review - Cardiology
AUGUST 19, 2024
"Discover the latest innovation in heart failure screening with an at-home testing device created by Colorado State University. Learn more at the American Chemi
DAIC
DECEMBER 18, 2024
12, 2024 Physicians have a new treatment option for many of the sickest pediatric patients with heart failure andcardiogenic shock. and Impella CP enable heart recovery as part of the world's smallest heart pump platform. Funding for this ACTION research program was provided by Abiomed, Inc.
52 
DAIC
MAY 30, 2024
milla1cf Thu, 05/30/2024 - 10:31 May 30, 2024 — Stereotaxis , a pioneer in surgical robotics for minimally invasive endovascular intervention, announced the successful treatment of the first heart rhythm patients by Penn Presbyterian Medical Center (PPMC) utilizing the advanced Genesis Robotic Magnetic Navigation System.
105 
DAIC
JULY 12, 2024
Pankaj Garg, MD mtaschetta-millane Fri, 07/12/2024 - 11:14 July 12, 2024 — Researchers have developed a groundbreaking method for analyzing heart MRI scans with the help of artificial intelligence , which could save valuable NHS time and resources, as well as improve care for patients. For more information: www.uea.ac.uk
122 
DAIC
FEBRUARY 21, 2024
However, there is a notable gap in device options for infants and young children with end stage heart failure. Although tools for the youngest heart patients are limited, the Ochsner Children’s Hospital team provides top-of-the-line care to bridge patients safely to transplant and a hope for a better quality of life.
105 
DAIC
FEBRUARY 18, 2025
In tricuspid valve regurgitation, a complex condition that Cedars-Sinai experts regularly treat, the valve between two heart chambers on the right side doesn't open or close properly. Catheter-based procedures offer an alternative for patients who are not candidates for open-heart surgery. Image by Getty.
52 
DAIC
JANUARY 15, 2024
Under the partnership with Pfizer, Ultromics will research and pursue FDA clearance for its EchoGo Amyloidosis algorithm that already has Breakthrough Device Designation as a medical device for the detection of cardiac amyloidosis. For more information: [link] References: 1 Maurer M, Elliott P, Comenzo R, et al.
119 
DAIC
JANUARY 5, 2024
Late-breaking Clinical Trials, Featured Clinical Research Sessions Announced for American College of Cardiology ACC.23/WCC Patients Implanted with Innovative FIRE1 Remote Heart Failure Monitoring System in Early Feasibility Study Atrial Fibrillation Market Reaches $20.92B, According to New Report 9.
DAIC
JUNE 11, 2024
Tricuspid and mitral valves are debilitating conditions that can lead to arrhythmias, hypertension, and heart failure. Until recently, therapeutic options for people with tricuspid and mitral valve disorders have been limited to symptom relief or high-risk surgery.
111 
DAIC
APRIL 5, 2024
milla1cf Fri, 04/05/2024 - 21:37 April 5, 2024 — The Cardiovascular Research Foundation (CRF) has announced New York Valves: The Structural Heart Summit , the expanded next iteration of our renowned annual Transcatheter Valve Therapy (TVT) conference. Taking place June 5-7, 2024, at the Jacob K.
52 
DAIC
JUNE 27, 2024
Anumana and InfoBionic.Ai, both Mayo Clinic portfolio companies,1,2 will continue to work closely with Mayo Clinic under this research agreement. “It ECG-AI LEF, the company’s FDA-cleared AI algorithm using routine 12-lead ECG data to detect low ejection fraction (LEF), a commonly undiagnosed indicator of heart failure,3 received U.S.
105 
DAIC
JANUARY 16, 2024
There, he served as an investigator in many high-profile clinical trials, including several significant structural heart studies. Dr. Shreenivas is a frequent speaker at major scientific meetings and has been widely published in peer-reviewed journals across the structural heart, heart failure, and coronary arenas.
DAIC
JULY 9, 2024
“While cardiologists are not the only determinants of cardiovascular outcomes, the lack of access to cardiologists in areas with greater prevalence of heart disease and mortality is incredibly concerning,” said Haider J. Upon analyzing all 3,143 U.S. Krumholz, MD, SM, FACC.
103 
Heart 2023 Conference
JANUARY 17, 2024
Koonlawee Nademanee, Director of the Bumrungrad Heart Institute in Thailand, have spearheaded the establishment of a world-class heart institute. This institute is dedicated to pioneering research, innovation, and the development of clinically effective techniques for addressing various heart conditions.
Frontiers in Cardiovascular Medicine
JUNE 28, 2024
Septic cardiomyopathy, a life-threatening complication of sepsis, can cause acute heart failure and carry a high mortality risk. It covers three innovative aspects: exosome surface modification technology, the use of exosomes as a multifunctional drug delivery platform, and plant exosome-like nanoparticle carriers.
DAIC
OCTOBER 4, 2024
2, 2024 — Eko Health recently announced a new independent study from researchers at Imperial College London (Imperial) that demonstrated how AI can identify patients with significantly higher risk of experiencing major adverse cardiac events (MACE), including heart attacks and heart failure.
ADN Center of Excellence
SEPTEMBER 2, 2024
AFib is associated with a fivefold increased risk of stroke, and it is also linked to heart failure, chronic fatigue, and other serious health issues. From advances in pharmacological treatments to innovative procedures like catheter ablation, the landscape of AFib treatment is continually evolving.
59 
Journal of the American Heart Association
APRIL 3, 2025
Journal of the American Heart Association, Ahead of Print. BackgroundMyocardial fibrosis is a pathological hallmark of heart failure post infarction, emphasizing the need for innovative treatment strategies.
DAIC
FEBRUARY 29, 2024
Five highly-anticipated late-breaking clinical trial sessions, an ACC/AHA guidelines update session and a host of featured clinical research sessions have been announced by program planners for the American College of Cardiology’s 73 rd Annual Scientific Session & Expo to be held April 6-8 in Atlanta, GA.
103 Circulation: Heart Failure
MARCH 28, 2025
Circulation: Heart Failure, Ahead of Print. We also emphasize the importance of continuous research and data sharing via national registries to refine CS team strategies and substantiate their effects on patient outcomes.
DAIC
DECEMBER 27, 2023
The adoption of the latest robotic magnetic navigation system represents our continued commitment to pursuing the innovative technologies and techniques that benefit our patients.” “For When left untreated, arrhythmias may significantly increase the risk of stroke, heart failure, and sudden cardiac arrest.
105 
Cardiometabolic Health Congress
OCTOBER 10, 2024
These innovative companies leverage AI to develop cutting-edge diagnostic tools, predictive analytics, and personalized medicine approaches. These companies are at the forefront of innovation, driving improvements in patient outcomes and reshaping the future of healthcare delivery.
52 
ADN Center of Excellence
SEPTEMBER 2, 2024
AFib is associated with a fivefold increased risk of stroke, and it is also linked to heart failure, chronic fatigue, and other serious health issues. From advances in pharmacological treatments to innovative procedures like catheter ablation, the landscape of AFib treatment is continually evolving.
52 
DAIC
DECEMBER 26, 2023
Krumholz, MD, SM, FACC milla1cf Tue, 12/26/2023 - 21:45 December 26, 2023 — Globally esteemed cardiologist and researcher, Harlan M. Professor of Medicine at the Yale School of Medicine and Director of the Y ale New Haven Hospital Center for Outcomes Research and Evaluation. Krumholz is the Harold H.
52 
DAIC
JUNE 11, 2024
Tricuspid and mitral valves are debilitating conditions that can lead to arrhythmias, hypertension, and heart failure. Until recently, therapeutic options for people with tricuspid and mitral valve disorders have been limited to symptom relief or high-risk surgery.
52 
DAIC
DECEMBER 19, 2023
The device is a patented 3-lead, 2-channel wireless continuous ECG wearable device that allows physicians the ability to address and assess sleep and heart health remotely. Peerbridge Health continues to innovate by compounding clinical utility in one simple device," said Andrea Natale, M.D., David's Medical Center. Kingshott, R.
DAIC
APRIL 5, 2024
milla1cf Fri, 04/05/2024 - 21:37 April 5, 2024 — The Cardiovascular Research Foundation (CRF) is excited to introduce New York Valves: The Structural Heart Summit , the expanded next iteration of our renowned annual Transcatheter Valve Therapy (TVT) conference. Taking place June 5-7, 2024, at the Jacob K.
DAIC
MARCH 25, 2025
Ten presentations will feature new data from the pivotal Phase III FINEARTS-HF cardiovascular (CV) outcomes trial, which investigated KERENDIA for treatingt adult patients with heart failure (HF) with a left ventricular ejection fraction (LVEF) of 40%, i.e., mildly reduced LVEF (HFmrEF) or preserved LVEF (HFpEF). Additional ACC.25
DAIC
APRIL 30, 2024
Getty Images milla1cf Tue, 04/30/2024 - 12:56 April 30, 2024 — A multicenter study led by Vanderbilt University Medical Center ( VUMC ) and Lipscomb University College of Pharmacy in Nashville has identified a potential new treatment for acute heart failure , a leading cause of hospitalization and death. hospitals from emergency rooms.
105 
Dr. Smith's ECG Blog
DECEMBER 27, 2018
I do research on Cardiologs' algorithm: Smith SW et al. Cardiologs founder, Yann Flereau, was named by MIT as the European Innovator of the Year. This ECG comes from Pierre Taboulet ( [link] /)( [link] ) an ECG whiz who codes a lot of ECGs for Cardiologs' Artificial Intelligence Deep Neural Network algorithm ( [link] ). What an honor.
40 
DAIC
MARCH 8, 2024
The research is funded by a four-year, $7.8 million grant awarded to Georgia Tech by the United States Department of Defense Congressionally Directed Medical Research Programs (CDMRP) as part of the agency’s call for the development of less invasive treatment technologies for cardiovascular conditions associated with cardiomyopathy.
98 
DAIC
MARCH 25, 2025
Ten presentations will feature new data from the pivotal Phase III FINEARTS-HF cardiovascular (CV) outcomes trial, which investigated KERENDIA for treatingt adult patients with heart failure (HF) with a left ventricular ejection fraction (LVEF) of 40%, i.e., mildly reduced LVEF (HFmrEF) or preserved LVEF (HFpEF). Additional ACC.25
DAIC
FEBRUARY 15, 2024
(AskBio), a subsidiary of Bayer AG, have announced that the first patient has been randomized in GenePHIT (Gene PHosphatase Inhibition Therapy), a Phase II trial of AB-1002, also known as NAN-101, for the treatment of congestive heart failure (CHF). It is estimated that 26 million worldwide are living with congestive heart failure.
CardiacWire
FEBRUARY 21, 2025
Competition breeds innovation, and thats good news for ATTR-CM patients who could have three different drugs to choose from: Vyndaqel (Pfizer), Attruby/Beyonttra (BridgeBio), and Amvuttra (Alnylam). The disease occurs when misfolded proteins build up in the heart and stiffen the heart muscle, leading to heart failure.
59 
DAIC
FEBRUARY 24, 2025
This article will explore how AI-driven diagnostics are reshaping cardiovascular medicine and how can healthcare leaders can leverage these innovations to improve patient care and control costs. Unplanned cardiac hospitalizations can be very expensive, with studies showing the cost of an index heart failure hospitalization averaging $13,000.
52 
Frontiers in Cardiovascular Medicine
JULY 11, 2024
Seidman, Christine E, Meder, Benjamin, Sinagra, Gianfranco were the most productive authors, German Centre for Cardiovascular Research was the most productive institution, and the USA, China, and Germany were the most prolific countries. Notable advances have been achieved in discovering and understanding the genetics of DCM.
Frontiers in Cardiovascular Medicine
JANUARY 10, 2024
Ischemic heart disease (IHD) is one of the world's foremost killers, accounting for 16% of all deaths worldwide. IHD is the main cause of heart failure (HF), as it leads to pathological changes in the heart, improper pumping function and eventual death.
DAIC
MARCH 31, 2025
These findings challenge the long-held assumption that frequent symptoms justify short-duration monitoring, said Mintu Turakhia, MD, iRhythm Chief Medical and Scientific Officer and EVP of Product Innovation. If left untreated, certain arrhythmias can damage the heart, brain, or other organs 4 and increase the risk of stroke or death.
52 
DAIC
FEBRUARY 22, 2024
In his year-long term as President of HVS, Dr. El-Hamamsy will focus on fostering collaboration among cardiologists, surgeons, and researchers, as well as promoting awareness and encouraging innovation to reduce the burden of heart valve disease globally.
142
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content